Stati Uniti - inglese - NLM (National Library of Medicine)

ax pharmaceutical corp - sermorelin acetate (unii: 00ibg87iqw) (sermorelin - unii:89243s03te) - sermorelin acetate .98 g in 1 g

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

serono limited - sermorelin acetate - pdr+solv for soln for inj - 50 microgram

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck serono ltd - sermorelin acetate - powder and solvent for solution for injection - 50microgram

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

serono limited - sermorelin acetate - pdr+solv for soln for inj - 50 microgram

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sermorelin 100 µg/ml - powder for injection - 100 mcg/ml - active: sermorelin 100 µg/ml

Israele - inglese - Ministry of Health

teva israel ltd - sertraline as hydrochloride - film coated tablets - sertraline as hydrochloride 50 mg - sertraline - sertraline - for the treatment of symptoms of depression in patients with or without a history of mania. following satisfactory response, continuation with sertaline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

Israele - inglese - Ministry of Health

teva israel ltd - sertraline as hydrochloride - film coated tablets - sertraline as hydrochloride 100 mg - sertraline - sertraline - for the treatment of symptoms of depression in patients with or without a history of mania. following satisfactory response, continuation with sertaline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - sertraline hydrochloride, quantity: 111.8 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; methylcellulose; magnesium stearate; hypromellose; hyprolose; titanium dioxide; iron oxide yellow; colloidal anhydrous silica; macrogol 8000 - sertraline is indicated in adults for the treatment of 1) major depression; 2) premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - sertraline hydrochloride, quantity: 55.9 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; methylcellulose; magnesium stearate; hypromellose; hyprolose; titanium dioxide; indigo carmine; colloidal anhydrous silica; macrogol 8000 - sertraline is indicated in adults for the treatment of 1) major depression; 2) premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sertraline hydrochloride, quantity: 111.9 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: hyprolose; sodium starch glycollate type a; titanium dioxide; polysorbate 80; microcrystalline cellulose; calcium hydrogen phosphate; macrogol 400; hypromellose; magnesium stearate - children and adolescents sertraline hydrochloride is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd.,adults sertraline hydrochloride is indicated for the treatment of: ? major depression, obsessive compulsive disorder (ocd) and panic disorder ? social phobia (social anxiety disorder) and the prevention of its relapse ? pre-menstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria